Desk›Healthcare› Mankind Pharma Ltd
Mankind Pharma Ltd
BSE 543904 · NSE MANKIND · ISIN INE634S01028 · Group A · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹2,387.40
-1.22%
BSE close, 28 August 2026
₹98,598.66 cr
41.3 cr shares · Mid cap
₹26,978.47 cr
as published
45.2× · 9.14×
EPS ₹52.80 · BV ₹261.20
10,421.18 / 2,037.56
₹ cr, as filed
34
9 selected · 26%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -10.6% |
|---|---|
| Against 52-week low | +25.0% |
| Day change | -1.22% |
| Size band | Mid cap |
| Index membership | NIFTY 500 |
Valuation as published by BSE
| Earnings per share | ₹52.80 |
|---|---|
| Price / earnings | 45.22× |
| Price / book | 9.14× |
| Book value — derived, price ÷ P/B | ₹261.20 |
| Return on equity | 20.21% |
| Operating margin | 32.47% |
| Net margin | 18.84% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 20.21%
- ROE as published
- 20.21%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 2,964.05 | 558.49 | 13.53 | 32.47% | 18.84% |
| Mar-26 · Q | 2,581.82 | 713.61 | 17.29 | 39.61% | 27.64% |
| FY25-26 | 10,421.18 | 2,037.56 | 49.37 | 31.72% | 19.55% |
Quarter on quarter
- Revenue, quarter on quarter
- +14.8%
- Net profit, quarter on quarter
- -21.7%
- Operating margin, quarter on quarter
- -714 bps
Disclosure profile 34 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Change in Management | 2 |
| Press Release | 2 |
| Board Outcome | 1 |
| Concall Transcript | 1 |
| Investor Presentation | 1 |
| Restructuring | 1 |
| Results | 1 |
| Selected sub-total | 9 |
| Procedural | |
| General | 7 |
| Analyst / Investor Meet | 3 |
| Postal Ballot | 3 |
| AGM / EGM | 2 |
| Newspaper Publication | 2 |
| Outcome | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| ESOP Allotment | 1 |
| Other Update | 1 |
| Subsidiary Incorporation | 1 |
| Trading Window | 1 |
| Procedural sub-total | 25 |
| Total | 34 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
34 filings · 9 selected · busiest 2026-07-30
Filing rhythm · the twelve most recent
2026-08-262026-10-09
SelectedProcedural
Filings
34 in the window · 14 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find attached certificate under Regulation 74(5) of the SEBI (DP) Regulations, 2018 for the quarter ended on September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
8 October 2026 ·
Board Meeting Intimation for Adoption Of Unaudited Financial Results
Mankind Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/10/2026 ,inter alia, to consider and approve the unaudited standalon and ....
Board Meeting / Board Meeting View filing →
-
28 September 2026 ·
Resignation Of Statutory Auditors Of A Material WOS
Please find attached intimation regarding resignation of Statutory Auditors of the Bharat Serums and Vaccines Limited, a matterial wholly owned subsidiary company.
Company Update / General View filing →
-
25 September 2026 ·
Closure of Trading Window
Please find attached, the intimation of clsoure of the trading window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
17 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Please find attached Voting Results of Postal Ballot and Scrutinizer's Report
AGM/EGM / Postal Ballot View filing →
-
17 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Please find attached Voting Results of Postal Ballot and Scrutinizer's Report
AGM/EGM / Postal Ballot View filing →
-
15 September 2026 ·
Intimation Regarding ESG Rating
Please find attached intimation regarding ESG Rating
Company Update / General View filing →
-
11 September 2026 ·
Analyst / Investor Meet - Intimation
Please find attached intimation of participation in the Investor Conferences
Company Update / Analyst / Investor Meet View filing →
-
7 September 2026 ·
Update On Voluntary Liquidation Of WOS
Please find attached update on voluntary liquidation of Bharat Serums and Vaccines Limited, a wholly owned subsidiary company.
Company Update / General View filing →
-
1 September 2026 ·
Allotment of ESOP / ESPS
Please find attached intimation regarding allotment of 49,112 equity shares pursuant to ESOP Plan
Company Update / Allotment of ESOP / ESPS View filing →
-
31 August 2026 ·
Update On Disinvestment
Please find attached final update on sale of stake of Broadway Hospitality Services Private Limited, a wholly owned subsidiary company.
Company Update / General View filing →
-
26 August 2026 ·
Restructuring
Please find attached outcome of the Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limited, a wholly ....
Company Update / Restructuring View filing →
-
26 August 2026 ·
Board Meeting Outcome for Dated August 26, 2026
Please find attached outcome of Board Meeting held today, according consent of the Board of Directors of the Company for the integration of Bharat Serums and Vaccines Limtied, a wholly ....
Others / Outcome without intimation View filing →
-
20 August 2026 ·
Press Release / Media Release
Please find attached press release dated August 20, 2026.
Company Update / Press Release / Media Release View filing →
-
19 August 2026 ·
Newspaper Publication
Please find attached Newspaper Advertisement of Notice of Postal Ballot
Company Update / Newspaper Publication View filing →
-
18 August 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find attched postal ballot notice
AGM/EGM / Postal Ballot View filing →
-
17 August 2026 ·
Completion Of Realignment Of Security Cover In Respect Of Non-Convertible Debentures And Consequent Release Of Pledged Shares Of Bharat Serums And Vaccines Limited
Completion of realignment of Security Cover in respect of Non-Convertible Debentures.
Company Update / General View filing →
-
13 August 2026 ·
Updates on Acquisition
Please find attached intimation regarding incorporation of a wholly owned subsidiary company in Netherlands
Company Update / Acquisition View filing →
-
10 August 2026 ·
Change in Management
Please find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
Company Update / Change in Management View filing →
-
10 August 2026 ·
Change in Management
Please find attached intimation regarding appointment of Mr. Anish Vanraj Bafna as Additional Director designated as Non-Executive Independent Director
Company Update / Change in Management View filing →
-
10 August 2026 ·
Board Meeting Outcome for For Appointment Of An Additional Director Designated As Non-Executive Independent Director
Please find attached outcome of board meeting
Others / Outcome without intimation View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Please find attached intimation regarding participation in Investor Conferences
Company Update / Analyst / Investor Meet View filing →
-
6 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find attached Voting Results and Scrutinizer's Report of 35th AGM
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find attached proceedings of the 35th AGM of the Company
AGM/EGM / AGM View filing →
-
4 August 2026 ·
Earnings Call Transcript
Please find attached transcript of the Investor Conference call for Q1FY27 held on July 30, 2026
Company Update / Earnings Call Transcript View filing →
-
31 July 2026 ·
Newspaper Publication
Please find attached Newspaper Advertisement - Unaudited Financial Results of the company for the quarter ended on June 30, 2026
Company Update / Newspaper Publication View filing →
-
30 July 2026 ·
Analyst / Investor Meet - Outcome
Investor Conference call for Q1FY27 - Audio Recording
Company Update / Analyst / Investor Meet View filing →
-
30 July 2026 ·
Compliances-Reg. 54 - Asset Cover details
Please find attached certificate under Regulation 54 of the SEBI (LODR) Regulations, 2015
Others / Reg. 54 - Asset Cover details View filing →
-
30 July 2026 ·
Press Release / Media Release
Please find attached press release on financial results of the Company for Q1FY27
Company Update / Press Release / Media Release View filing →
-
30 July 2026 ·
Investor Presentation
Please find attached investor presentation for Q1FY27
Company Update / Investor Presentation View filing →
-
30 July 2026 ·
Approval For Issuance Of Corporate Guarantee
Board of Directors of the Company in its meeting held today has inter-alia considered and approved the issuance of corproate guarantee in favour of Bharat Serums & Vaccines Limited, a WOS.
Company Update / General View filing →
-
30 July 2026 ·
Un-Audited Financial Results Of The Company For The Quarter Ended On June 30, 2026
Please find attached un-audited financial results of the Company for the quarter ended on June 30, 2026
Result / Financial Results View filing →
-
30 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
27 July 2026 ·
Final Update On Stake Sale Of Broadway Hospitality Services Private Limited
Intimation under Regulation 30 of the SEBI LODR
Company Update / General View filing →
RSS feed for Mankind Pharma Ltd · the 50 most recent filings